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Abstract
This cross-sectional study aimed to estimate the 
prevalence of hyperuricemia and associated risk 
factors among Japanese-Brazilians. We obtained 
data on demographic, health history, food intake, 
and laboratory variables. Chi-square and preva-
lence ratios were used as measures of association. 
35.3% of the subjects presented hyperuricemia, 
which was more frequent in smokers, males, age ≥ 
55 years, with co-morbidities, individuals on uric 
acid-increasing medication, serum creatinine > 
1.4mg/dL, high alcohol consumption, and low 
consumption of milk and dairy products. In the 
multivariate analysis, the associations remained 
significant with gender, overweight, central obe-
sity, hypertriglyceridemia, and use of specific 
drugs. Among males, low intake of saturated fat 
was associated with hyperuricemia. Individuals 
with hypertension showed a negative associa-
tion with dairy product consumption. The high 
hyperuricemia prevalence suggests that changes 
in nutritional profile and control of associated 
co-morbidities could help minimize occurrence 
of this condition.
Hyperuricemia; Diet; Japanese-Brazilians
Introduction
The scientific literature makes widespread ref-
erence to the association between chronic non-
communicable diseases, especially rheumat-
ic and cardiovascular diseases, and hyperurice-
mia 1,2,3. The relationship between excess plasma 
uric acid and gout is described in the literature, 
but despite all the studies and technological ad-
vances, there is still limited evidence to show a 
direct relationship between hyperuricemia and 
cardiovascular diseases 3,4,5.
According to previous studies, some foods can 
help increase or decrease the serum uric acid lev-
els 6,7,8, depending on their purine content. There 
is still little information on the exact amount of 
purines contained in foods, since their content 
and availability depend on the food processing 
procedures, among other factors 4,9,10.
Various studies 3,8,11,12,13 have pointed to 
excessive intake of fat, alcohol, and fructose, 
as well as changes in body weight (both excess 
weight and sudden weight loss) as risk factors for 
hyperuricemia. In addition, a reduction in the 
consumption of protein-rich foods (especially 
animal protein) can help decrease the blood uric 
acid levels 11,13. The literature includes reports 
that excess body fat may be the most important 
nutritional factor for hyperuricemia 2,4,14.
According to previous publications, hype-
ruricemia is associated with various chronic 
diseases such as arterial hypertension, cardio-
ARTIGO   ARTICLE
Poletto J et al.370
Cad. Saúde Pública, Rio de Janeiro, 27(2):369-378, fev, 2011
vascular diseases, obesity, dyslipidemias, dia-
betes mellitus, metabolic syndrome, gout, and 
some neoplasms which increase the risk of death 
themselves 5,15,16,17. Gout is a rheumatic disease 
characterized by the deposit of sodium monou-
rate in the joints and periarticular tissues, and is 
one of the main diseases resulting from hyperu-
ricemia. Individuals with gout have low quality 
of life resulting from activity-limiting symptoms 
like intense pain and inflammation of the affect-
ed joints 1,2,13.
Importantly, some medicines indicated for 
the treatment of the above-mentioned chronic 
diseases (like arterial hypertensions and neo-
plasms) include elevated plasma uric acid levels 
as one of their side effects 2,4,5,14,18.
Studies among first-generation (Issei) and 
second-generation (Nisei) Japanese immigrants 
residing in Bauru, São Paulo State, Brazil, show 
that these individuals present high prevalence 
rates for these chronic diseases: excess weight 
(22.4%), central obesity (67%), arterial hyperten-
sion (42.4% in Isseis and 33.2% in Niseis), dys-
lipidemia (81.9% in Isseis and 77.4% in Niseis) 19, 
altered fasting glucose (18%), decreased glucose 
tolerance (32%), diabetes mellitus (29%), and 
metabolic syndrome (47,3%) 20. Given this situ-
ation, the current study aimed to estimate the 
prevalence of hyperuricemia among these indi-
viduals and identify metabolic, anthropometric, 
dietary, and lifestyle risk factors associated with 
this condition.
Methodology
This study used data from cross-sectional epide-
miological research from the second phase of a 
study by the Japanese-Brazilian Diabetes Study 
Group (JBDSG) in the Japanese-Brazilian com-
munity (Japanese and their descendents) in the 
municipality of Bauru, from 1999 to 2000. The 
research project was approved by the Institution-
al Review Board of the Federal University in São 
Paulo (UNIFESP).
In the original research, following a census 
of the Japanese-Brazilian community in Bauru, 
the next step was to identify and invite to partici-
pate in the study all the first-generation (born in 
Japan) and second-generation individuals (chil-
dren of the first generation, born in Brazil, exclud-
ing children of ethnic intermarriage), age ≥ 30 
years, totaling 1,751 Japanese-Brazilians of both 
genders. Of the total group invited to participate, 
1,330 accepted (76%). Of the 421 (24%) that did 
not participate, 57 had moved out of the munici-
pality or out of the country, 94 died before or dur-
ing the data collection period, and 270 refused 
to participate in the study. Details on the study 
design have been published elsewhere 20,21.
After agreeing to participate in the study by 
signing a free and informed consent form, partic-
ipants were interviewed by trained interviewers 
using standardized, previously tested question-
naires in order to obtain information on socio-
demographic aspects (gender, age, generation, 
and marital status), health – personal and family 
history of illnesses (systemic arterial hyperten-
sion, dyslipidemia, glucose intolerance, cancer, 
and regular use of medications), and smoking.
Food consumption was assessed with a food 
frequency questionnaire, previously validated for 
Japanese-Brazilians 22. Participants were asked 
about their habitual food and food-group con-
sumption (122 items) during the previous year. 
Dietary nutrients were calculated using Dietsys 
4.01 (National Cancer Institute, Bethesda, USA) 23. 
The nutrient databases used were from the Unit-
ed States Department of Agriculture, in addition 
to the food chemical composition tables for Bra-
zil 24 and Japan 25.
In order to study the relationship between hy-
peruricemia and dietary variables, we analyzed 
the data for consumption of alcohol, total calo-
ries, carbohydrates, proteins, lipids, and the food 
groups with the highest content of purines or that 
in some way impact serum uric acid concentra-
tion, like red meats, processed meats, milk and 
dairy products, and fruits (no food consumption 
information was available for 47 subjects).
The physical exams and laboratory tests were 
performed at the Hospital for Rehabilitation of 
Cranio-Facial Anomalies in Bauru. Body weight 
was measured in kilograms on a platform-type 
anthropometric scale (Filizola brand) with a ca-
pacity of 200kg and accurate to 100g, positioned 
on a flat surface and calibrated at each weighing. 
Individuals were weighed barefoot and wearing 
as little clothing as possible. Height was measured 
with a manual stadiometer, attached to the wall, 
with a capacity of 2 meters and accurate to 1cm, 
with the individual barefoot and the buttocks, 
trunk, and head pressed against the wall, without 
a baseboard, and on a smooth flat surface and 
with arms hanging by the individual’s side. Body 
mass index (BMI) was calculated as weight (in ki-
lograms), divided by height (in meters) squared. 
We adopted the recommendations of the World 
Health Organization (WHO) 26 for classification 
of individual nutritional status. Normal weight 
was defined as BMI from 18.5 to 24.9kg/m2, over-
weight as BMI 25 to 29.9kg/m2, and obesity as 
BMI ≥ 30kg/m2.
Waist circumference was measured to the 
closest 0.1cm with a non-extensible tape mea-
sure at the height of the umbilicus. This mea-
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surement was taken with the individual standing 
upright, abdomen relaxed, arms beside the body, 
and feet together. Central (or abdominal) obesity 
was defined as ≥ 80 and 90cm for females and 
males, respectively 27.
Systolic (SBP) and diastolic blood pressure 
(DBP) measurements were taken by trained phy-
sicians, using automatic digital devices with the 
cuff adjusted to the brachial circumference (mod-
el HEM712C, Omron Brazil), after the individual 
had rested 10 minutes in the sitting position. 
Three measurements were taken, and the final 
value was defined as the mean of the latter two 
measurements expressed in millimeters of mer-
cury (mmHg). The diagnostic criterion for arterial 
hypertension was based on the seventh report of 
the United States Joint National Committee on 
Prevention, Detection, Evaluation and Treatment 
of High Blood Pressure (JNC-7) 28. High blood 
pressure or arterial hypertension was defined as 
SBP ≥ 140mmHg or DBP ≥ 90mmHg or regular use 
of medication for hypertension (self-reported).
Information on the use of medicines that 
interfere in serum uric acid concentration (thi-
azides, furosemide, allopurinol, and tamoxifen) 
was also obtained during the physical examina-
tion, as was data on use of vitamin supplements.
Serum uric acid was quantified with the 
uricase method. Hyperuricemia was defined as 
serum uric acid > 6mg/dL for women and > 7mg/
dL for men 4,14.
The Jaffé method was used to measure serum 
creatinine, and loss of renal function was defined 
as creatinine > 1.4mg/dL 29.
Venous blood (first sample, minimum 10 
hours fasting) was used to measure glucose, lipid 
profile (total cholesterol, fractions, and triglycer-
ides), uric acid, and creatinine. Two hours after a 
75g glucose load, the second sample was taken to 
measure plasma glucose only, using the glucose 
oxidase method. The glucose load was only used 
in individuals who did not report a previous diag-
nosis of diabetes mellitus, who were not on medi-
cation for diabetes, and presented capillary fast-
ing glucose < 200mg/dL. Capillary blood glucose 
was measured with a glucose meter (Glucostix/
Glucometer System). Blood glucose alterations 
were classified according to WHO criteria 30.
Enzymatic kits were use to quantify lipopro-
teins. Lipid profile alterations were diagnosed on 
the basis of information on use of lipid-lowering 
drugs and cutoff points recommended by the Na-
tional Cholesterol Education Program – ATP III 31: 
total cholesterol ≥ 200mg/dL, LDL-cholesterol ≥ 
130mg/dL, HDL-cholesterol < 45mg/dL, or trig-
lycerides ≥ 150mg/dL.
Individuals were defined as on use of uric 
acid-increasing medication with the following 
drugs: thiazides, furosemide, allopurinol, and 
tamoxifen 2,22.
Statistical analysis
The chi-square test was used for comparisons of 
individuals with or without hyperuricemia ac-
cording to health-related, socio-demographic, 
and anthropometric variables (in categorical 
form). The measure of association was point 
prevalence ratio (PR) with a 95% confidence in-
terval (95%CI).
In order to verify the existence of associations 
between habitual diet and hyperuricemia, di-
etary variables were adjusted for total calories as 
recommended by Willet 32. To describe the data, 
the dietary values were grouped in consumption 
tertiles, and for each tertile we obtained the me-
dian nutrient consumption, number of cases of 
hyperuricemia, and PR values.
A Poisson regression model was used to ad-
just the effects of the main target variables – total 
calories, lipids, saturated fats, alcohol, processed 
meats, fish, milk and dairy products (values for 
dietary variables in tertiles), body mass index, 
central obesity – on hyperuricemia for the con-
trol variables (gender, generation, age, marital 
status, smoking, arterial hypertension, serum 
creatinine > 1.4mg/dL, degree of glucose toler-
ance, hypercholesterolemia, hypertriglyceri-
demia, elevated LDL, and use of medication). 
These variables were selected because they 
showed p-values < 0.20 in the crude analysis. 
These procedures were repeated separately for 
males and females, for the presence of arterial 
hypertension, and after exclusion of individuals 
on medication.
The data were analyzed with Stata, version 
10.0 for Windows (Stata Corp., College Station, 
USA).
Results
Among the 1,330 Japanese-Brazilians that partic-
ipated in this study, 470 (35.3%; 95%CI: 32.8-38.0) 
presented uric acid levels consistent with hype-
ruricemia, while only 19 individuals (4%) had 
a previous diagnostic of this condition. Table 1 
shows data on the Japanese-Brazilians’ demo-
graphic and social characteristics according to 
presence of hyperuricemia. Elevated serum uric 
acid levels were more frequent in males (PR = 
1.76; 95%CI: 1.52-2.05) and individuals 55 years 
or older (PR = 1.18; 95%CI: 1.01-1.37). There was 
a similar distribution of Japanese-Brazilians with 
and without hyperuricemia according to genera-
tion and marital status (p > 0.05).
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In both men and women, prevalence of hype-
ruricemia was lower among younger individuals 
(men 49% and women 24%); however, this differ-
ence was only statistically significant in women 
(women < 55 years, 24% and women ≥ 55 years, 
76%; p < 0.05).
Table 2 shows the hyperuricemia prevalence 
rates according to anthropometric and health 
characteristics. Among Japanese-Brazilians with 
overweight or obesity, the hyperuricemia rates 
were 2.25 (95%CI: 1.83-2.77) and 3.25 times high-
er (95%CI: 2.50-4.23) than in normal weight indi-
viduals. In the presence of central obesity, prev-
alence of hyperuricemia was 2.36 times higher 
(95%CI: 2.01-2.78) than in individuals without 
this condition. Higher hyperuricemia prevalence 
rates were found in individuals with co-morbid-
ities like arterial hypertension (PR = 1.54; 95%CI: 
1.34-1.78), glucose intolerance (altered fasting 
glucose: PR = 1.69; 95%CI: 1.25-2.29; decreased 
glucose tolerance: PR = 2.08; 95%CI: 1.39-3.11; 
diabetes mellitus: PR = 2.32; 95%CI: 1.73-3.12), 
hypercholesterolemia (PR = 1.30; 95%CI: 1.11-
1.52), hypertriglyceridemia (PR = 2.34; 95%CI: 
1.90-2.88), and smoking (PR = 1.30; 95%CI: 1.13-
1.51), when compared to individuals without 
these conditions. Of the 32 individuals with loss 
of renal function (assessed as elevated creati-
nine level), 20 (62.5%) presented hyperuricemia 
(PR = 1.80; 95%CI: 1.36-2.28). No associations 
were observed between prevalence of hyperuri-
cemia and altered HDL and LDL-cholesterol lev-
els, or individuals with a history of cancer (data 
not shown).
Among individuals on hyperuricemic medi-
cation (especially diuretics, n = 110), 69 pre-
sented hyperuricemia (Table 2); this proportion 
was higher than among individuals not on such 
medication (PR = 1.91; 95%CI: 1.62-2.25). Only 31 
individuals (2.3%) used vitamin C supplements, 
10 of whom showed hyperuricemia (data not 
shown).
Table 3 shows higher hyperuricemia rates 
among individuals that consumed more alcohol 
per day (PR = 1.56; 95%CI: 1.26-1.92) and fewer 
dairy products (PR = 0.64; 95%CI: 0.51-0.81).
Table 4 shows the results from the Poisson 
regression model. There was an association be-
tween hyperuricemia and gender, higher BMI 
(overweight and obesity), central obesity, hyper-
triglyceridemia, and hyperuricemic medication, 
independently of variables like diet, age, genera-
tion, marital status, smoking, arterial hyperten-
sion, glucose tolerance, hypercholesterolemia, 
elevated LDL, and serum creatinine > 1.4mg/dL.
In the analysis by gender, among women, age 
was also associated positively with hyperurice-
mia (PR = 1.95; 95%CI: 1.36-2.78), while among 
men, the use of medication lost its statistical sig-
nificance and consumption of saturated fats was 
associated negatively with hyperuricemia (2nd 
versus 1st tertile: PR = 0.72; 95%CI: 0.53-0.98). 
Table 1
Number (percentage) of Japanese-Brazilians with hyperuricemia, p-values, and prevalence ratios according to demographic 
and social characteristics. Bauru, São Paulo State, Brazil, 1999-2000.
 Variable Hyperuricemia p-value * PR (95%CI)
 Yes No Total
   n % n % n %
 Gender        
  Male 283 46 331 54 614 100 < 0.001 1.76 (1.52-2.05)
  Female 187 26 529 74 716 100  1.00
 Age bracket (years)        
  ≥ 55 288 38 475 62 763 100 0.033 1.18 (1.01-1.37)
  < 55 182 32 385 68 567 100  1.00
 Generation        
  Second (Nisei) 383 36 678 64 1,061 100 0.180 1.14 (0.94-1.39)
  First (Issei) 81 32 175 68 256 100  1.00
 Marital status        
  Married 370 37 642 63 1,102 100 0.083 1.17 (0.98-1.41)
  Other ** 97 31 214 69 311 100  1.00
PR: prevalence ratio; 95%CI: 95% confi dence interval.
* p-values for chi-square test;
** Other: single, widow(er), separated, or divorced.
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Finally, upon repeating the analyses according 
to presence of arterial hypertension, among in-
dividuals with high blood pressure, there was a 
negative association between hyperuricemia and 
consumption of milk and dairy products (3rd ver-
sus 1st tertile: PR = 0.66; 95%CI: 0.47-0.94). The 
exclusion of the group of individuals on hyperu-
ricemic medication did not alter these results.
Discussion
In this study, the high prevalence of hyperurice-
mia among Japanese-Brazilians (35.3%) corrob-
orates previous findings by the JBDSG empha-
sizing the high cardiovascular risk among these 
individuals. In this community, along with the 
glucose intolerance “epidemic”, studies have also 
shown high prevalence rates for dyslipidemia, 
arterial hypertension, metabolic syndrome, and 
central obesity, all of which at higher rates than 
Table 2
Number (percentage) of Japanese-Brazilians with hyperuricemia, p-values, and prevalence ratios according to anthropometric and health characteristics. Bauru, 
São Paulo State, Brazil, 1999-2000.
 Variable Hyperuricemia p-value * PR (95%CI)
 Yes No Total
   n % n % n %
 Body mass index (kg/m2)        
  Underweight 7 18 33 82 40 100 < 0.001 0.82 (0.39-1.76)
  Normal weight 145 21 538 79 683 100  1.00
  Overweight 228 48 249 52 477 100  2.25 (1.83-2.77)
  Obesity 89 69 40 31 129 100  3.25 (2.50-4.23)
 Central obesity        
  Yes 306 50 301 50 607 100 < 0.001 2.36 (2.01-2.78)
  No 163 23 559 77 722 100  1.00
 Arterial hypertension        
  Yes 229 45 278 55 507 100 < 0.001 1.54 (1.34-1.78)
  No 241 29 581 71 822 100  1.00
 Glucose tolerance        
  Normal 56 20 228 80 284 100 < 0.001 1.00
  Altered fasting glucose 158 33 316 67 474 100  1.69 (1.25-2.29)
  Decreased glucose tolerance 41 41 59 59 100 100  2.08 (1.39-3.11)
  Diabetes 212 46 251 54 463 100  2.32 (1.73-3.12)
 Hypercholesterolemia        
  Yes 324 39 515 61 839 100 0.001 1.30 (1.11-1.52)
  No 146 30 345 70 491 100  1.00
 Hypertriglyceridemia        
  Yes 379 44 489 56 868 100 < 0.001 2.34 (1.90-2.88)
  No 83 19 361 81 444 100  1.00
 Smoking        
  Yes (current or former) 173 42 237 58 906 100 < 0.001 1.30 (1.13-1.51)
  No 293 32 613 68 410 100  1.00
 Use of medication        
  Yes ** 69 63 41 37 110 100 < 0.001 1.91 (1.62-2.25)
  No 401 33 819 67 1,220 100  1.00
 Serum creatinine > 1.4mg/dL        
  Yes 20 63 12 37 32 100 0.001 1.80 (1.36-2.38)
  No 450 35 848 65 1,298 100  1.00
PR: prevalence ratio; 95%CI: 95% confi dence interval.
* p-values for chi-square test;
** Medications used by participants for various treatments and that interfere in serum uric acid concentration (thiazides, furosemide, allopurinol, and 
tamoxifen).
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Table 3
Number (percentage) of Japanese-Brazilians with hyperuricemia according to dietary variables (in tertiles). Bauru, São Paulo State, Brazil, 1999-2000.
 Variable Hyperuricemia p-value * PR (95%CI)
 Yes No Total
   n % n % n %
 Calories (kcal)        
  First tertile (1,433) 131 31 296 69 427 100 0.060 1.00
  Second tertile (1,918.8) 161 38 267 62 428 100  1.23 (0.97-1.54)
  Third tertile (2,506.3) 159 37 269 63 428 100  1.21 (0.96-1.53)
 Carbohydrates (g)        
  First tertile (185.1) 155 36 272 64 427 100 0.277 1.00
  Second tertile (253.4) 138 32 291 68 429 100  0.89 (0.70-1.11)
  Third tertile (341.7) 158 37 269 63 427 100  1.02 (0.82-1.27)
 Proteins (g)        
  First tertile (46.1) 156 38 256 62 412 100 0.349 1.00
  Second tertile (65.2) 148 35 281 65 429 100  0.91 (0.73-1.14)
  Third tertile (88.1) 147 33 295 67 442 100  0.88 (0.70-1.10)
 Lipids (g)        
  First tertile (47.8) 169 39 267 61 436 100 0.146 1.00
  Second tertile (68.2) 142 34 279 66 421 100  0.87 (0.70-1.09)
  Third tertile (95.7) 140 33 286 67 426 100  0.85 (0.68-1.06)
 Saturated fats (g)        
  First tertile (10.4) 171 41 251 59 422 100 0.019 1.00
  Second tertile (15.7) 139 33 288 67 427 100  0.80 (0.64-1.00)
  Third tertile (23.9) 141 33 293 67 434 100  0.80 (0.64-1.00)
 Alcohol (g/day) **        
  None 249 33 517 67 766 100 < 0.001 1.00
  1.0-3.7 71 28 187 72 258 100  0.85 (0.65-1.10)
  > 3.7 131 51 128 49 259 100  1.56 (1.26-1.92)
 Red meat group (g)        
  First tertile (17.3) 142 33 285 67 427 100 0.379 1.00
  Second tertile (41.6) 146 34 281 66 427 100  1.03 (0.82-1.30)
  Third tertile (80.0) 159 38 264 62 423 100  1.13 (0.90-1.42)
 Processed meats group (g)        
  First tertile (2.3) 131 32 278 68 409 100 0.127 1.00
  Second tertile (8.8) 139 35 263 65 402 100  1.08 (0.85-1.37)
  Third tertile (22.5) 157 39 248 61 405 100  1.21 (0.96-1.53)
 Fish group (g)
  First tertile (5.2) 134 32 290 68 424 100 0.161 1.00
  Second tertile (13.4) 153 37 262 63 415 100  1.17 (0.93-1.47)
  Third tertile (32.4) 157 37 265 63 422 100  1.18 (0.93-1.48)
 Milk and dairy products
 group (g)
  First tertile (2.1) 181 42 247 58 428 100 < 0.001 1.00
  Second tertile (56.6) 153 36 272 64 425 100  0.85 (0.69-1.06)
  Third tertile (200.0) 116 27 313 73 429 100  0.64 (0.51-0.81)
 Fruits group (g)        
  First tertile (132.6) 144 34 283 66 427 100 0.666 1.00
  Second tertile (331.5) 149 35 276 65 425 100  1.04 (0.83-1.31)
  Third tertile (602.1) 158 37 273 63 431 100  1.09 (0.87-1.36)
PR: prevalence ratio; 95%CI: 95% de confi dence interval.
* p-values for chi-square test;
** Due to the number of individuals that reported not consuming alcohol, we chose to set the cutoff for categories 2 and 3 as the median value of those that 
reported some consumption of alcoholic beverages.
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in the overall Brazilian population or in Japanese 
living in Japan 19,21,33,34.
In Brazil, there are no available data from pop-
ulation-based epidemiological studies on the oc-
currence of altered serum uric acid levels. Despite 
the recognition of the limitations in the direct 
comparison between findings from the current 
study and those of other researchers (particularly 
because of the different age structures in these 
population groups and the different approaches 
used), one can state that the prevalence of hype-
ruricemia detected among Japanese-Brazilians 
(35.3%) was higher than described in interna-
tional studies 11,35,36. As identified in previous 
publications by the JBDSG 19,21,33,34, this commu-
nity also displays high rates of co-morbidities as-
sociated with hyperuricemia, thus characterizing 
high risk for cardiovascular diseases.
The literature has still not totally elucidated 
the mechanism by which excess body fat leads 
to increased serum uric acid. In addition to the 
increase in endogenous production of urate, evi-
dence shows that accumulated visceral fat leads 
to an increase in free fatty acids and tumor necro-
sis factor alpha (TNF-α), together with a decrease 
in adiponectin concentration, which leads in turn 
to reduced renal excretion of uric acid 4,8,14. The 
current study’s findings show a positive associa-
tion between elevated serum uric acid and excess 
body weight and central obesity. Such findings 
are consistent with those of other studies 37,38,39.
Hypertriglyceridemia is found frequently in 
individuals with asymptomatic hyperuricemia 
or gout 5,14. Some studies suggest that hyper-
triglyceridemia and arteriosclerosis result from 
metabolic abnormalities inherent to gout 3,40. 
According to the current study’s data, hyperu-
ricemia and hypertriglyceridemia are positively 
associated with each other. This relationship is 
still not totally clear in the literature, but there is 
purportedly a reduced renal excretion of uric acid 
in individuals with hyperuricemia and dyslipi-
demia 41. Other studies have also shown a posi-
tive association between hypertriglyceridemia 
and hyperuricemia 37,38,39,41.
Uric acid renal transport is explained by a 
four-component system: glomerular filtration, 
proximal tubular reabsorption, tubular secre-
tion, and post-secretory reabsorption. This sys-
tem allows understanding the action of drugs 
that decrease urinary uric acid excretion (which 
increase serum uric acid levels) and those that 
augment urinary uric acid excretion (and de-
crease serum uric acid levels) 4,14. Some drugs 
used for the treatment of arterial hypertension 
and other diseases like neoplasms increase the 
serum uric level levels. This effect is due to the 
fact that they decrease urinary uric acid excre-
tion, which leads to renal tubular reabsorption of 
uric acid, resulting in most cases from stimula-
tion of the URAT-1 transporter which promotes 
a reduction in the urinary excretion of this sub-
stance 2,5,18. Among the Japanese-Brazilians who 
were using hyperuricemic medication, there was 
a higher prevalence of excess uric acid. Other au-
thors have reported a similar association 12,39.
This study showed differences between the 
genders and age brackets. The most important 
Table 4
Adjusted prevalence ratios (95% confi dence interval) for presence of hyperuricemia and the remaining variables. Bauru, São 
Paulo State, Brazil, 1999-2000.
 Variable Hyperuricemia (yes versus no)
   Initial model Final model
   PR (95%CI) PR (95%CI)
 Gender (male versus female) 1.65 (1.25-2.18) 1.73 (1.42-2.10)
 Body mass index (kg/m2)  
  Underweight 0.92 (0.37-2.29) 1.08 (0.50-2.32)
  Normal weight 1.00 1.00
  Overweight 1.56 (1.16-2.11) 1.55 (1.19-2.02)
  Obesity 1.96 (1.33-2.89) 1.95 (1.38-2.75)
 Central obesity (yes versus no) 1.33 (1.01-1.80) 1.42 (1.09-1.84)
 Hypertriglyceridemia (yes versus no) 1.52 (1.16-2.00) 1.68 (1.31-2.15)
 Use of medications (yes versus no) 1.42 (1.03-1.95) 1.53 (1.17-2.01)
PR: prevalence ratio; 95%CI: 95% confi dence interval.
Note: variables included in the initial model: total calories, lipids, saturated fats, alcohol, processed meats group, fi sh group, 
milk and dairy products group, citric fruits group, age, generation, marital status, smoking, arterial hypertension, glucose 
tolerance, hypercholesterolemia, elevated LDL, and serum creatinine > 1.4mg/dL.
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difference was in women over 55 years of age, 
probably due to menopause, common in women 
in this age bracket, which leads to increased se-
rum uric acid due to the deficiency of estrogen, 
a hormone that purportedly increases urinary 
excretion of uric acid 3,39.
Among men the results were different: the 
use of hyperuricemic drugs lost its statistical sig-
nificance, and consumption of saturated fats was 
negatively associated with the prevalence of hy-
peruricemia, that is, there was a lower prevalence 
of hyperuricemia among men that consumed 
less saturated fat. This finding lacks backing in 
the scientific literature and probably reflects a 
phenomenon frequently cited in cross-sectional 
studies – reverse causality – given that one ob-
serves high rates of metabolic alterations like ar-
terial hypertension and diabetes mellitus among 
Japanese-Brazilians, suggesting that they have 
modified their eating habits.
When analyzing this sample of Japanese-Bra-
zilians according to presence of arterial hyper-
tension, among the individuals with high blood 
pressure there was a negative association be-
tween consumption of milk and dairy products 
and increased plasma uric acid levels, indicating 
that hyperuricemia rates were lower among indi-
viduals that consumed more milk and dairy prod-
ucts. According to a review study by Schlesinger 9, 
casein and lactalbumin – proteins present in milk 
– apparently play a uric acid-excreting role, since 
they are related to reductions in serum uric acid 
in healthy individuals; in addition, adherence to 
a dairy-poor diet can lead to an increase in uric 
acid levels. The current study’s findings were also 
consistent with results reported elsewhere in the 
literature 4,11,13.
Alcohol abuse can contribute to the occur-
rence of hyperuricemia due to the increase in 
metabolic production of uric acid and the de-
crease in renal uric acid excretion 2,4. A cohort 
study in Taiwan from 1993 to 1996 showed asso-
ciation between alcohol consumption and hype-
ruricemia in males, while 11.7g of ethanol per day 
from beer increased serum uric acid by 0.08mg/
dL 11. However, in the current study, the associa-
tion between alcohol intake and hyperuricemia 
lost is statistical significance after adjusting for 
control variables. In the results shown here, this 
association was not maintained after multivari-
ate adjustment. Still, it is important to highlight 
that in the studies evaluating alcohol content ac-
cording to type of beverage, the positive associa-
tion between alcohol consumption and hyperu-
ricemia was mostly related to beer 4,11,16.
The relationship between consumption of 
animal protein (especially red meat) and hype-
ruricemia has been reported in the literature 4,8,9. 
However, in the current study such an association 
did not show statistical significance in the crude 
analysis.
This study presents some limitations: (1) the 
cross-sectional design does not allow inferring 
a causal relationship between the independent 
variables and the outcome; (2) despite the rec-
ommendation by various studies concerning 
the ideal anatomical point (midway between 
the anterior superior iliac spine and the last 
rib) for measuring the waist circumference, the 
researchers in the second phase of the JBDSG 
study opted to use the most convenient anatomi-
cal landmark, the umbilical scar; (3) one cannot 
rule out the possibility of data collection errors 
on habitual food consumption, since the latter 
depends exclusively on the interviewees’ recall 
capacity (although the use of trained interview-
ers and a previously tested instrument possibly 
minimized this bias). In addition, despite the 
known inherent limitations of the FFQ (Food 
Frequency Questionnaire), it shows good capac-
ity to identify subjects in extreme consumption 
categories; (4) dietary information was collected 
by means of a FFQ validated for the study popu-
lation, however more precise data on the types of 
food consumed and their purine content could 
not be assessed due to methodological and logis-
tic difficulties; (5) no information was available 
on acute weight loss and isolated fructose con-
sumption; and (6) despite the lack of information 
on food consumption for 3.5% of the subjects 
(n = 47), there is no reason to suppose that the 
findings would have been different if these data 
had been available for all of the subjects (this 
group was considered small and incapable of 
modifying the findings).
Finally, according to this study, gender (male), 
excess weight (overweight or obesity), hypertrig-
lyceridemia, and use of medication that interferes 
in serum uric acid concentration were associated 
with hyperuricemia, independently of other risk 
factors. During the multivariate analysis the as-
sociations that had been observed between hy-
peruricemia and dietary variables (alcohol and 
milk and dairy product consumption) lost their 
statistical significance.
The findings suggest the need (in both clini-
cal practice and public health) to monitor the 
effect of medications that can affect uric acid 
metabolism, to encourage consumption of three 
portions of milk and dairy products, and to pro-
mote changes in individuals’ nutritional profile, 
like reduction in weight, body fat, and serum 
triglycerides, thus contributing to a decrease in 
hyperuricemia rates.
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Resumo
O objetivo deste estudo transversal foi estimar a pre-
valência de hiperuricemia e fatores associados entre 
nipo-brasileiros. Obtiveram-se informações sobre 
variáveis demográficas, de saúde, dietéticas e bioquí-
micas. O teste qui-quadrado e razões de prevalências 
foram utilizados como medidas de associação. 35,3% 
dos sujeitos tinham hiperuricemia e esta acometeu, 
principalmente, tabagistas, homens, com faixa etária 
≥ 55 anos, com outras comorbidades, em uso de drogas 
hiperuricemiantes, com creatinina sérica elevada, com 
maior ingestão de álcool e menor de laticínios. Em 
análise múltipla permaneceram significantes as asso-
ciações com o sexo, excesso de peso, obesidade central, 
hipertrigliceridemia e uso de medicamentos. Entre 
os homens, o menor consumo de gorduras saturadas 
associou-se à hiperuricemia. Entre hipertensos ocorreu 
associação negativa com o consumo de laticínios. A al-
ta prevalência de hiperuricemia indica que mudanças 
no perfil nutricional e controle das comorbidades as-
sociadas podem contribuir para minimizar a ocorrên-
cia dessa anormalidade.
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